journal article·2016-01

Rational design of multifunctional magnetic mesoporous silica nanoparticle for tumor-targeted magnetic resonance imaging and precise therapy

Wei-Hai Chen, Guo-Feng Luo, Qi Lei, Feng-Yi Cao, Jin-Xuan Fan, Wen-Xiu Qiu, Hui-Zhen Jia, Sheng Hong, Fang Fang, Xuan Zeng, Ren-Xi Zhuo, Xian-Zheng Zhang

Biomaterials· Volume 76
Publisher page

Abstract

In this paper, a multifunctional theranostic magnetic mesoporous silica nanoparticle (MMSN) with magnetic core was developed for magnetic-enhanced tumor-targeted MR imaging and precise therapy. The gatekeeper β-cyclodextrin (β-CD) was immobilized on the surface of mesoporous silica shell via platinum(IV) prodrug linking for reduction-triggered intracellular drug release. Then Arg-Gly-Asp (RGD) peptide ligand was further introduced onto the gatekeeper β-CD via host-guest interaction for cancer targeting purpose. After active-targeting endocytosis by cancer cells, platinum(IV) prodrug in MMSNs would be restored to active platinum(II) drug in response to the innative reducing microenvironment in cancer cells, resulting in the detachment of β-CD gatekeeper and thus simultaneously triggering the in situ release of anticancer drug doxorubicin (DOX) entrapped in the MMSNs to kill cancer cells. It was found that with the aid of an external magnetic field, drug loaded MMSNs showed high contrast in MR imaging in vivo and exhibited magnetically enhanced accumulation in the cancer site, leading to significant inhibition of cancer growth with minimal side effects. This multifunctional MMSN will find great potential as a theranostic nanoplatform for cancer treatment.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Dendrimers and Hyperbranched Polymers

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (53)

Show source-provided references
1. Nanocarriers as an emerging platform for cancer therapy10.1038/nnano.2007.387 ↗
2. Nanoparticle delivery of cancer drugs10.1146/annurev-med-040210-162544 ↗
3. In vivo targeted delivery of nanoparticles for theranosis10.1021/ar2000138 ↗
4. Facile synthesis of monodisperse superparamagnetic Fe3O4 Core@hybrid@Au shell nanocomposite for bimodal imaging and photothermal therapy10.1002/adma.201103521 ↗
5. Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model10.1021/nn200809t ↗
6. Enhancing accumulation and penetration of HPMA copolymer-doxorubicin conjugates in 2D and 3D prostate cancer cells via iRGD conjugation with an MMP-2 cleavable spacer10.1021/jacs.5b00922 ↗
7. Multifunctional tumor pH-sensitive self-assembled nanoparticles for bimodal imaging and treatment of resistant heterogeneous tumors10.1021/ja4108287 ↗
8. Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery10.1021/ja207150n ↗
9. MMP-2 responsive polymeric micelles for cancer-targeted intracellular drug delivery10.1039/C4CC07563C ↗
10. Engineering the assemblies of biomaterial nanocarriers for delivery of multiple theranostic agents with enhanced antitumor efficacy10.1002/adma.201204750 ↗
11. Multifunctional envelope-type mesoporous silica nanoparticles for tumor-triggered targeting drug delivery10.1021/ja312004m ↗
12. Multifunctional Fe5C2 nanoparticles: a targeted theranostic platform for magnetic resonance imaging and photoacoustic tomography-guided photothermal therapy10.1002/adma.201305811 ↗
13. Mesoporous silica nanoparticles for intracellular controlled drug delivery10.1002/smll.200901789 ↗
14. Mechanized silica nanoparticles: a new frontier in theranostic nanomedicine10.1021/ar200018x ↗
15. MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition10.1002/adma.201303123 ↗
16. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery10.1002/adma.201104763 ↗
17. A reversible molecular valve10.1073/pnas.0504109102 ↗
18. Multifunctional mesoporous silica nanoparticles for cancer-targeted and controlled drug delivery10.1002/adfm.201201316 ↗
19. Cell-specific intracellular anticancer drug delivery from mesoporous silica nanoparticles with pH sensitivity10.1002/adhm.201100030 ↗
20. Glutathione-induced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gatekeepers10.1002/adma.201001417 ↗
21. Enzyme-responsive snap-top covered silica nanocontainers10.1021/ja0772086 ↗
22. Engineering a hollow nanocontainer platform with multifunctional molecular machines for tumor-targeted therapy in vitro and in vivo10.1021/nn404676w ↗
23. Polyvalent nucleic acid/mesoporous silica nanoparticle conjugates: dual stimuli-responsive vehicles for intracellular drug delivery10.1002/anie.201005471 ↗
24. Magnetic fluorescent delivery vehicle using uniform mesoporous silica spheres embedded with monodisperse magnetic and semiconductor nanocrystals10.1021/ja0565875 ↗
25. Fabrication of uniform magnetic nanocomposite spheres with a magnetic core/mesoporous silica shell structure10.1021/ja051113r ↗
26. Self-assembly of mesoporous nanoscale silica/gold composites10.1021/la034522e ↗
27. Antimicrobial activity of silver nanocrystals encapsulated in mesoporous silica nanoparticles10.1002/adma.200802646 ↗
28. Core-shell-type magnetic mesoporous silica nanocomposites for bioimaging and therapeutic agent delivery10.1002/adma.201401124 ↗
29. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery10.1021/nn800072t ↗
30. A smart nanoassembly for multistage targeted drug delivery and magnetic resonance imaging10.1002/adfm.201303662 ↗
31. Formation of oligonucleotide-gated silica shell-coated Fe3O4-Au core-shell nanotrisoctahedra for magnetically targeted and near-infrared light-responsive theranostic platform10.1021/ja504118q ↗
32. A magnetic, luminescent and mesoporous core-shell structured composite material as drug carrier10.1016/j.biomaterials.2009.05.038 ↗
33. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery10.1002/anie.200802469 ↗
34. Magnetic targeting enhanced theranostic strategy based on multimodal imaging for selective ablation of cancer10.1002/adfm.201303345 ↗
35. Iron oxide @polypyrrole nanoparticles as a multifunctional drug carrier for remotely controlled cancer therapy with synergistic antitumor effect10.1021/nn4017179 ↗
36. Multifunctional Fe3O4@polydopamine core-shell nanocomposites for intracellular mRNA detection and imaging-guided photothermal therapy10.1021/nn500722y ↗
37. Chemical synthesis and assembly of uniformly sized iron oxide nanoparticles for medical applications10.1021/acs.accounts.5b00038 ↗
38. Multifunctional mesoporous nanoellipsoids for biological bimodal imaging and magnetically targeted delivery of anticancer drugs10.1002/adfm.201001495 ↗
39. Targeted theranostic platinum(IV) prodrug with a built-in aggregation-induced emission light-up apoptosis sensor for noninvasive early evaluation of its therapeutic responses in situ10.1021/ja411811w ↗
40. Neuropilin-1-targeted gold nanoparticles enhance therapeutic efficacy of platinum(IV) drug for prostate cancer treatment10.1021/nn500152u ↗
41. MSN-mediated sequential vascular-to-cell nuclear-targeted drug delivery for efficient tumor regression10.1002/adma.201402752 ↗
42. Noninvasive imaging of αvβ3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography
43. Encapsulation of an adamantane-doxorubicin prodrug in pH-responsive polysaccharide capsules for controlled release10.1021/am301258a ↗
44. Dual-targeting pro-apoptotic peptide for programmed cancer cell death via specific mitochondria damage10.1038/srep03468 ↗
45. Superparamagnetic high-magnetization microspheres with an Fe3O4@SiO2 core and perpendicularly aligned mesoporous SiO2 shell for removal of microcystins10.1021/ja0777584 ↗
46. Redox activation of metal-based prodrugs as a strategy for drug delivery10.1016/j.addr.2012.01.007 ↗
47. A targeted theranostic platinum(IV) prodrug containing a luminogen with aggregation-induced emission (AIE) characteristics for in situ monitoring of drug activation10.1039/c3cc49516g ↗
48. Multifunctional magnetic nanoparticles for targeted imaging and therapy10.1016/j.addr.2008.03.014 ↗
49. Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo
50. Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier10.1016/j.biomaterials.2009.06.026 ↗
51. Rational design of multifunctional gold nanoparticles via host–guest interaction for cancer-targeted therapy10.1021/acsami.5b04031 ↗
52. Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats10.1007/s11095-008-9763-4 ↗
53. Protective effect of N-acetylcysteine, caffeic acid and vitamin E on doxorubicin hepatotoxicity10.1177/0960327107076885 ↗